Found 67 clinical trials
Plaque Psoriasis
Plaque psoriasis is a skin condition that causes red, scaly bumps to appear anywhere on the body, and is often described as itchy and painful. The pain and itching can feel quite overwhelming
- 33 views
- 23 Sep, 2021
- 1 location
SPROUT - Pediatric Psoriasis - CC-10004 PPSO 003 - Canada
This is a Phase 3, multicenter, randomized, placebo-controlled, double-blind study of the efficacy and safety of apremilast (CC-10004) in pediatric subjects with moderate to severe plaque
- 0 views
- 05 Sep, 2022
Clinical Study to Assess the Efficacy and Safety of Tildrakizumab in the Treatment of Moderate to Severe Nail Psoriasis.
This study is for adults, 18 or older with a clinical diagnosis of chronic moderate to severe plaque-type psoriasis that has been present for at least 6 months. Subjects must also have moderate to severe psoriasis of the nails at the screening and baseline visits and who are considered candidates …
- 3 views
- 04 May, 2022
- 1 location
Do You Have Plaque Psoriasis?
We are currently enrolling qualified participants in a clinical research study for an investigational topical lotion.
- 103 views
- 23 Nov, 2020
- 1 location
Are you Suffering from Chronic Plaque Psoriasis?
Are you Suffering from Chronic Plaque Psoriasis?
- 990 views
- 25 Mar, 2021
- 1 location
You may be interested in learning about a clinical research study of an investigational study medication for symptoms associated with plaque psoriasis
You may be interested in learning about a clinical research study of an investigational study medication for symptoms associated with plaque psoriasis
- 128 views
- 08 Nov, 2020
- 1 location
A single-arm study to assess the immunogenicity and safety of etanercept produced using a modified process in subjects with plaque psoriasis
A single-arm study to assess the immunogenicity and safety of etanercept produced using a modified process in subjects with plaque psoriasis
- 154 views
- 08 Nov, 2020
- 1 location
A Phase 3, Multi-site, randomized, mixed-blind, parallel-group treatment withdrawl and re-treatment study of the efficacy and safety of 2 oral doses of CP-690,550 in Subjects with Moderate to Severe Chronic Plaque Psoriasis
Chronic Plaque Psoriasis
- 465 views
- 08 Nov, 2020
- 1 location
A double-blind, randomized, parallel-group vehicle-controlled, multi-center study comparing a generic tazarotene cream, 0.05% to reference listed drug tazorac (tazarotene) cream, 0.05% and both active treatments to a vehicle control in the treatment of plaque psoriasis
active treatments to a vehicle control in the treatment of plaque psoriasis
- 186 views
- 08 Nov, 2020
- 1 location